Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
Pentoxifylline (Trental) a new vasoactive agent was shown to be a powerful inhibitor of ADP and serotonin induced platelet aggregation of monkey platelets in vivo. A linear dose response curve was demonstrated between 6 and 24 mg/kg of i.v. pentoxifylline.